
TY  - JOUR
AU  - Eyre, Toby A.
AU  - Clifford, Ruth
AU  - Bloor, Adrian
AU  - Boyle, Lucy
AU  - Roberts, Corran
AU  - Cabes, Maite
AU  - Collins, Graham P.
AU  - Devereux, Stephen
AU  - Follows, George
AU  - Fox, Christopher P.
AU  - Gribben, John
AU  - Hillmen, Peter
AU  - Hatton, Chris S.
AU  - Littlewood, Tim J.
AU  - McCarthy, Helen
AU  - Murray, Jim
AU  - Pettitt, Andrew R.
AU  - Soilleux, Elizabeth
AU  - Stamatopoulos, Basile
AU  - Love, Sharon B.
AU  - Wotherspoon, Andrew
AU  - Schuh, Anna
TI  - NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 175
IS  - 1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.14177
DO  - doi:10.1111/bjh.14177
SP  - 43
EP  - 54
KW  - Ofatumumab
KW  - CHOP
KW  - TP53
KW  - Richter syndrome
KW  - Chronic lymphocytic leukaemia
PY  - 2016
AB  - Richter syndrome (RS) is associated with chemotherapy resistance and a poor historical median overall survival (OS) of 8?10 months. We conducted a phase II trial of standard CHOP-21 (cyclophosphamide, doxorubicin, vincristine, prednisolone every 21 d) with ofatumumab induction (Cycle 1: 300 mg day 1, 1000 mg day 8, 1000 mg day 15; Cycles 2?6: 1000 mg day 1) (CHOP-O) followed by 12 months ofatumumab maintenance (1000 mg given 8-weekly for up to six cycles). Forty-three patients were recruited of whom 37 were evaluable. Seventy-three per cent were aged >60 years. Over half of the patients received a fludarabine and cyclophosphamide-based regimen as prior CLL treatment. The overall response rate was 46% (complete response 27%, partial response 19%) at six cycles. The median progression-free survival was 6·2 months (95% confidence interval [CI] 4·9?14·0 months) and median OS was 11·4 months (95% CI 6·4?25·6 months). Treatment-naïve and TP53-intact patients had improved outcomes. Fifteen episodes of neutropenic fever and 46 non-neutropenic infections were observed. There were no treatment-related deaths. Seven patients received platinum-containing salvage at progression, with only one patient obtaining an adequate response to proceed to allogeneic transplantation. CHOP-O with ofatumumab maintenance provides minimal benefit beyond CHOP plus rutuximab. Standard immunochemotherapy for RS remains wholly inadequate for unselected RS. Multinational trials incorporating novel agents are urgently needed.
ER  - 

TY  - JOUR
TI  - The Society of Academic and Research Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S6
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7350
DO  - doi:10.1002/bjs.7350
SP  - 1
EP  - 6
PY  - 2010
AB  - Abstract The Annual Meeting of the Society of Academic and Research Surgeons was held at the Royal Free Hospital, London on Wednesday 6th and Thursday 7th January 2010 under the Presidency of Professor Norman Williams. The Patey Prize was awarded to Mr Stephen McNally from the MRC Centre for Inflammation Research, University of Edinburgh and University Department of Surgery, Royal Infirmary of Edinburgh, for his presentation entitled HEME ARGINATE AMELIORATES HEPATIC ISCHAEMIA REPERFUSION INJURY THROUGH MODIFICATION OF MACROPHAGE PHENOTYPE. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

AU  - Seijo, Susana
AU  - DeLeve, Laurie D.
C7  - pp. 2171-2182
TI  - Vascular Diseases of the Liver
SN  - 9781118512067
UR  - https://doi.org/10.1002/9781118512074.ch111
DO  - doi:10.1002/9781118512074.ch111
SP  - 2171-2182
KW  - Systemic circulatory disease
KW  - portal vein thrombosis
KW  - Budd-Chiari syndrome
KW  - adaptation to heterogeneous perfusion
KW  - nodular regenerative hyperplasia
KW  - portal hypertension
KW  - sinusoidal obstruction syndrome
KW  - anticoagulation
KW  - myeloproliferative neoplasms
KW  - peliosis hepatis
PY  - 2010
AB  - Summary This chapter provides an overview of vascular diseases of the liver. Several rare diseases are included within this term, the most important being Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), sinusoidal obstruction syndrome (SOS) and adaptation to heterogenous perfusion. BCS and PVT are mainly caused by prothrombotic diseases and they frequently develop non-cirrhotic portal hypertension-related complications. SOS is caused most often by drugs and chemotherapy regimens and its clinical presentation ranges from asymptomatic to severe hepatic and multiorgan failure. The term adaptation to heterogenous perfusion includes a variety of rare entities such as nodular regenerative hyperplasia, hepatoportal sclerosis, non-cirrhotic portal cirrhosis, and obliterative portal venopathy, suggesting that they could constitute a single entity with a common pathogenic mechanism that results in a spectrum of pathological lesions and clinical manifestations. This chapter also considers ischemic hepatitis, congestive hepatopathy and peliosis hepatis.
ER  - 

AU  - McGurk, Paula
AU  - Elia, Marinos
AU  - Zazzo, Jean-Fabien
C7  - pp. 208-229
TI  - Nutrition and the Pancreas
SN  - 9781405168106
UR  - https://doi.org/10.1002/9781119211945.ch13
DO  - doi:10.1002/9781119211945.ch13
SP  - 208-229
KW  - diabetes mellitus
KW  - diet
KW  - insulin
KW  - intravenous feeding
KW  - nasogastric feeding
KW  - nutrition
KW  - pancreas
PY  - 2010
AB  - Summary The management of diabetes is underpinned by observations that good metabolic control can not only prevent short-term problems, such as those associated with hypo- and hyperglycaemia, but also long-term complications. Special nutritional problems, including those involving nasogastric and intravenous feeding, are discussed in this chapter. There are three main groups of oral drugs that are commonly used in the treatment of type 2 diabetes: biguanides, sulphonylureas, and thiazolidinediones. An insulin pump attempts to imitate the healthy pancreas, although it delivers insulin into the peripheral circulation, whereas the pancreas delivers it into the portal circulation, which produces important 'first-pass' metabolic effects in the liver. In summary, while the healthy diet for healthy people is also generally appropriate for people with diabetes, there are also specific considerations associated with the timing of food ingestion.
ER  - 

TY  - JOUR
TI  - GLIA Edinburgh 2017: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 65
IS  - S1
SN  - 9781405168106
UR  - https://doi.org/10.1002/glia.23157
DO  - doi:10.1002/glia.23157
SP  - E103
EP  - E578
PY  - 2017
ER  - 

TY  - JOUR
TI  - Motility/Neurogastroenterology
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_10.x
DO  - doi:10.1111/j.1440-1746.2011.07251_10.x
SP  - 150
EP  - 157
PY  - 2012
ER  - 

TY  - JOUR
TI  - IBD Clinical
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_6.x
DO  - doi:10.1111/j.1440-1746.2011.07251_6.x
SP  - 96
EP  - 122
PY  - 2012
ER  - 

TY  - JOUR
TI  - Nutrition Clinical
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_9.x
DO  - doi:10.1111/j.1440-1746.2011.07251_9.x
SP  - 140
EP  - 149
PY  - 2012
ER  - 

TY  - JOUR
TI  - Second World Union of Wound Healing Societies
JO  - Wound Repair and Regeneration
VL  - 13
IS  - 3
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1067-1927.2004.130321.x
DO  - doi:10.1111/j.1067-1927.2004.130321.x
SP  - A49
EP  - A87
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Pediatric Dermatology
JA  - Pediatr Dermatol
VL  - 36
IS  - S1
SN  - 9781405168106
UR  - https://doi.org/10.1111/pde.13846
DO  - doi:10.1111/pde.13846
SP  - S9
EP  - S53
PY  - 2019
ER  - 

TY  - JOUR
TI  - Concurrent Sessions Posters
JO  - HPB
JA  - HPB
VL  - 15
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/hpb.12093
DO  - doi:10.1111/hpb.12093
SP  - 85
EP  - 244
PY  - 2013
ER  - 

TY  - JOUR
AU  - Stief, C.
AU  - Minhas, S.
TI  - MP-04 Surgery, Peyronie’s Disease, and Priapism
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_11.x
DO  - doi:10.1111/j.1743-6109.2007.00390_11.x
SP  - 143
EP  - 147
PY  - 2007
ER  - 

TY  - JOUR
TI  - PP-05 Surgery, Priapism, and Peyronie's Disease
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_17.x
DO  - doi:10.1111/j.1743-6109.2007.00390_17.x
SP  - 185
EP  - 194
PY  - 2007
ER  - 

TY  - JOUR
AU  - Hatzichristou, D.
AU  - Wespes, E.
TI  - P-04 Pharmacology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_4.x
DO  - doi:10.1111/j.1743-6109.2007.00390_4.x
SP  - 114
EP  - 117
PY  - 2007
ER  - 

TY  - JOUR
AU  - Chen, J.
AU  - Arver, S.
TI  - P-05 Ejaculatory Disorders
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_5.x
DO  - doi:10.1111/j.1743-6109.2007.00390_5.x
SP  - 118
EP  - 121
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Artificial Organs
VL  - 29
IS  - 9
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1525-1594.2005.01114_1.x
DO  - doi:10.1111/j.1525-1594.2005.01114_1.x
SP  - 716
EP  - 787
PY  - 2005
ER  - 

TY  - JOUR
TI  - Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/tri.12210
DO  - doi:10.1111/tri.12210
SP  - 1
EP  - 184
PY  - 2013
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - Paediatrics
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_11.x
DO  - doi:10.1111/j.1440-1746.2011.07251_11.x
SP  - 158
EP  - 160
PY  - 2012
ER  - 

TY  - JOUR
TI  - Subspeciality Poster Sessions
JO  - European Journal of Clinical Investigation
VL  - 34
IS  - s1
SN  - 9781405168106
UR  - https://doi.org/10.1111/j.1365-2362.2004.00001.x
DO  - doi:10.1111/j.1365-2362.2004.00001.x
SP  - 1
EP  - 19
PY  - 2004
ER  - 
